It has been shown that in patients with T2DM, the use of losartan, a blocker of the binding of angiotensin II (ANGII) to its AT1R receptor reduced proteinuria and increased Klotho levels, demonstrating the inverse association between these two factors [64]. This evidence concerns the gene KL and type 2 diabetes mellitus.